Microbiota and arthritis: cause or consequence?


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
05 2024
Historique:
received: 22 02 2024
accepted: 15 03 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: ppublish

Résumé

The relationship between intestinal microbiota and arthritis has garnered significant attention, with emerging evidence suggesting a potential association between dysbiosis and various forms of inflammatory arthropathies. While observational studies have provided valuable insights into microbiota alterations in patients with arthritis, establishing causality remains challenging. Observational data, influenced by multiple confounders such as environmental factors, medication effects, and dietary habits, are insufficient to conclusively determine whether microbiota changes are somehow causally linked to arthritis. The heterogeneity of results across independent studies further complicates interpretation. To further support this hypothesis, interventional randomised trials are deemed necessary, yet their implementation in this area presents significant technical limitations. Experimental animal models offer insights into potential pathogenic mechanisms linking dysbiosis to arthritis, including compromised intestinal barrier function, the role of microbiota-derived metabolites and molecular mimicry. However, conflicting findings underscore the complexity of hostmicrobiota interactions and the challenges in establishing causality.Efforts to modulate the microbiota for arthritis treatment or prevention have shown promise, yet efficacy and applicability remains uncertain. Antibacterial drugs, dietary interventions, probiotics, and faecal microbiota transplantation have been explored, but their clinical utility awaits further validation. In conclusion, while the association between intestinal microbiota and arthritis is increasingly recognised, establishing causality remains elusive.

Identifiants

pubmed: 38743445
pii: 20936
doi: 10.55563/clinexprheumatol/f6q4dc
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1097-1103

Auteurs

Giacomo Cafaro (G)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Giulia Cruciani (G)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Lorenza Bruno (L)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Roberto Dal Pozzolo (R)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Anna Colangelo (A)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Francesco Tromby (F)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Martina Nicchi (M)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Biancamaria Pianese (B)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Carlo Perricone (C)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Roberto Gerli (R)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy. roberto.gerli@unipg.it.

Elena Bartoloni (E)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH